Delivery Order SPE2DB20D3103-SPE2DB26FL5R7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Promacta 25 mg tablets (30-count units) with a ceiling value of $8,836.12 and a firm fixed price structure. This delivery order, which is expected to complete by October 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-unit packages) under a firm fixed price contract. The delivery order was issued on October 20, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $24,079.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Promacta 50 mg tablets (30-count units). The contract, which represents a non-competitive set-aside award, is scheduled for completion by December 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $13,254.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 25 mg tablets (30-count unit of use packaging). The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Promacta 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $16,053.06 and an ultimate completion date of August 26, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December...
- The Defense Logistics Agency awarded a delivery order valued at $8,836.12 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets (30-count packaging) with a completion date of September 4, 2025. The competitive, firm fixed-price award was issued on August 13, 2025, with no set-aside designation. AmerisourceBergen will perform the work at its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,026.53 with firm fixed pricing and is scheduled for completion by November 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5R7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-count units) on November 10, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, with the IDC serving as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical supplies to military healthcare programs worldwide. This delivery order will be performed at AmerisourceBergen's Conshohocken facility and reflects the company's established role as a primary supplier for the Defense Health Agency and other federal healthcare systems. Promacta (eltrombopag) is an immunosuppressant used in military medical treatment facilities for eligible patients. The award demonstrates AmerisourceBergen's continued capacity to meet federal pharmaceutical procurement requirements through open competition, consistent with the company's extensive portfolio of medical product deliveries covering specialty medications, vaccines, and therapeutic commodities across multiple healthcare domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 11/10/25 |